Citi analyst Daniel Grosslight raised the firm’s price target on McKesson (MCK) to $713 from $630 and keeps a Buy rating on the shares. The analyst updated health technology models post the Q3 reports.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MCK:
- Cigna drops pursuit of Humana: Morning Buzz
- McKesson, Oracle among finalists looking to buy Veradigm, Axios reports
- McKesson price target raised to $651 from $642 at TD Cowen
- JPMorgan, Five Below downgraded: Wall Street’s top analyst calls
- Early notable gainers among liquid option names on November 7th